Trial Profile
Pharmacokinetics of ABT-335 and Rosuvastatin in Subjects With Normal Renal Function and Renal Impairment.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Oct 2012
Price :
$35
*
At a glance
- Drugs Choline fenofibrate (Primary) ; Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 21 Mar 2012 Additional lead trial investigator (Maureen Kelly) identified as reported by ClinicalTrials.gov.
- 21 Mar 2012 Official title amended as reported by ClinicalTrials.gov.
- 26 Nov 2008 New trial record.